Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cusan

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 1, 1988
Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamideS Moorjani, A Dupont, F Labrie, et al.
Cancer Surveys|January 1, 1995
Downstaging by combination therapy with flutamide and an LHRH agonist before radical prostatectomyF Labrie, L Cusan, J L Gomez, et al.
Biology of Reproduction|May 1, 1981
Relative importance of the adenohypophyseal and gonadal sites in inhibitory action of LHRH agonistsC Séguin, A Bélanger, L Cusan, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Combination therapy with flutamide and [D-Trp6]LHRH ethylamide for stage C prostatic carcinomaA Dupont, F Labrie, M Giguere, et al.
Cancer Metastasis Reviews|January 1, 1987
Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experienceF Labrie, A Dupont, A Bélanger, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1988
Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinomaF Labrie, A Dupont, M Giguere, et al.
Progress in Clinical and Biological Research|January 1, 1989
Combination therapy with flutamide and castration: its benefits at various stages of prostate cancerF Labrie, A Dupont, L Cusan, et al.
L'Union Medicale Du Canada|January 1, 1989
[Total androgen blockade: an argument in favor]F Labrie, Y Lacourcière, A Bélanger, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1997
Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancerJ Laverdière, J L Gomez, L Cusan, et al.
Hormone Research|January 1, 1983
New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonistF Labrie, A Dupont, A Belanger, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Endocrinology and Metabolism|February 1, 1988
Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamideS Moorjani, A Dupont, F Labrie, et al.
Cancer Surveys|January 1, 1995
Downstaging by combination therapy with flutamide and an LHRH agonist before radical prostatectomyF Labrie, L Cusan, J L Gomez, et al.
Biology of Reproduction|May 1, 1981
Relative importance of the adenohypophyseal and gonadal sites in inhibitory action of LHRH agonistsC Séguin, A Bélanger, L Cusan, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Combination therapy with flutamide and [D-Trp6]LHRH ethylamide for stage C prostatic carcinomaA Dupont, F Labrie, M Giguere, et al.
Cancer Metastasis Reviews|January 1, 1987
Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experienceF Labrie, A Dupont, A Bélanger, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1988
Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinomaF Labrie, A Dupont, M Giguere, et al.
Progress in Clinical and Biological Research|January 1, 1989
Combination therapy with flutamide and castration: its benefits at various stages of prostate cancerF Labrie, A Dupont, L Cusan, et al.
L'Union Medicale Du Canada|January 1, 1989
[Total androgen blockade: an argument in favor]F Labrie, Y Lacourcière, A Bélanger, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1997
Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancerJ Laverdière, J L Gomez, L Cusan, et al.
Hormone Research|January 1, 1983
New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonistF Labrie, A Dupont, A Belanger, et al.
Pageof 10